SCHEMBL954141

SCHEMBL954141

O=C(/C=C1\CCCc2c1cnn2-c1ccccc1)N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
LMNA P02545 2/20 0.44
POLB P06746 1/20 0.42
TMEM97 Q5BJF2 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
ELANE P08246 1/20 0.40
AKR1C3 P42330 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD11B1 P28845 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
CA9 Q16790 1/20 0.39
NPC1 O15118 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3R2 O00459 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL954142 1.00 ALDH1A1 (0.45) ALDH1A1LMNAPOLBTMEM97SIGMAR1
SCHEMBL959665 0.82 CA1 (0.45) ALDH1A1LMNAPOLBHSD17B10RAB9A
SCHEMBL959664 0.82 CA1 (0.45) ALDH1A1LMNAPOLBHSD17B10RAB9A
Oxalic Acid SCHEMBL954036 0.80 SIGMAR1 (0.47) ALDH1A1LMNAPOLBTMEM97SIGMAR1
Oxalic Acid SCHEMBL954037 0.80 SIGMAR1 (0.47) ALDH1A1LMNAPOLBTMEM97SIGMAR1
SCHEMBL954470 0.78 SIGMAR1 (0.51) ALDH1A1LMNAPOLBTMEM97SIGMAR1
SCHEMBL957532 0.78 SIGMAR1 (0.51) ALDH1A1LMNAPOLBTMEM97SIGMAR1
SCHEMBL954469 0.78 SIGMAR1 (0.51) ALDH1A1LMNAPOLBTMEM97SIGMAR1
SCHEMBL960003 0.75 ALDH1A1 (0.47) ALDH1A1HSD17B10RAB9ASMN1; SMN2CA1
SCHEMBL960002 0.75 ALDH1A1 (0.47) ALDH1A1HSD17B10RAB9ASMN1; SMN2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394797-B2 Substituted pyrazole sigma receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2013-03-12 US disclosed
EP-1781619-B1 SIGMA RECEPTOR INHIBITORS ESTEVE LABOR DR (ES) 2011-08-17 EP disclosed
US-20110015183-A1 SUBSTITUTED PYRAZOLE SIGMA RECEPTOR ANTAGONISTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2011-01-20 US disclosed
US-7829559-B2 Substituted pyrazole sigma receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2010-11-09 US disclosed
US-20070232585-A1 Sigma Receptor Inhibitors LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-10-04 US disclosed
EP-1781619-A1 SIGMA RECEPTOR INHIBITORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-05-09 EP disclosed
WO-2006021463-A1 SIGMA RECEPTOR INHIBITORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015183-A1 SUBSTITUTED PYRAZOLE SIGMA RECEPTOR ANTAGONISTS SIGMAR1, OPRK1, OPRD1 ALDH1A1 1244/4885LMNA 3612/4885POLB 1839/4885
US-20070232585-A1 Sigma Receptor Inhibitors SIGMAR1, OPRK1, OPRL1 ALDH1A1 1180/4885LMNA 3545/4885POLB 1607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.